Bou Nasser Eddine, F., Forlani, G., Lombardo, L., Tedeschi, A., Tosi, G., & Accolla, R. S. (2016). CIITA-driven MHC class II expressing tumor cells can efficiently prime naive CD4(+) TH cells in vivo and vaccinate the host against parental MHC-II-negative tumor cells. Oncoimmunology.

Bou Nasser Eddine, Farah, Greta Forlani, Letizia Lombardo, Alessandra Tedeschi, Giovanna Tosi, e Roberto S. Accolla. "CIITA-driven MHC Class II Expressing Tumor Cells Can Efficiently Prime Naive CD4(+) TH Cells in Vivo and Vaccinate the Host against Parental MHC-II-negative Tumor Cells." Oncoimmunology 2016.

Bou Nasser Eddine, Farah, et al. "CIITA-driven MHC Class II Expressing Tumor Cells Can Efficiently Prime Naive CD4(+) TH Cells in Vivo and Vaccinate the Host against Parental MHC-II-negative Tumor Cells." Oncoimmunology 2016.